Regulatory Affairs for Support Staff

This two-day course provides an introduction to pharmaceutical regulatory affairs and the basics of drug development and has been designed specifically for those working in a support staff role.

19-20 Mar 2020

& 29-30 Sep 2020

GBP 1,299
EUR 1,819
USD 2,026

Book now

Course overview

Working in pharmaceutical regulatory affairs is a complex role, with involvement in not only the drug development stages but also post drug-approval activities and marketing.

This interactive course, designed specifically for those working in a support staff role, provides a valuable introduction to pharmaceutical regulatory affairs and key responsibilities.

Participants will gain an overview of the EU regulatory procedures required to register products in Europe and the regulatory activities that need to be complied with to keep products on the market.

The programme will cover pharmacovigilance and safety reporting with sessions on licence variations, the commercial aspects of pharmaceutical products and the potential impact of Brexit. The course will provide a thorough grounding in the subject of regulatory affairs and enable support staff to perform more effectively.

Discussion sessions and the use of case studies throughout the two days will help consolidate learning.

Benefits of attending:

  • Understand the background of EU law – regulations, directives and guidelines
  • Consider the potential impact of Brexit
  • Gain an understanding of the Common Technical Document n Discuss how to apply for a marketing authorisation in the EU – the centralised, decentralised and mutual recognition procedures
  • Clarify post-authorisation obligations – pharmacovigilance, variations and renewals
  • Assess the impact of the EU Clinical Trial Regulation

Who should attend

This course is designed for anyone working in regulatory affairs including administrators, assistants and any member of support staff wishing to gain a greater understanding of regulatory affairs in the pharmaceutical industry.

It is also suitable for those who interface with the regulatory affairs function and provide support to the regulatory procedures and activities.

Programme - Day one

European law – regulations, directives and guidelines
  • Impact of Brexit
Where can we find information on regulatory affairs?
  • The internet/publications
  • Approvals and withdrawals
The drug development process
  • Drug discovery
  • Pharmaceutical R&D
  • Non-clinical tests
  • Clinical studies – Phase I to IV
  • Registration


The EU Clinical Trials Directive and new Clinical Trial Regulation

  • What is the process for running clinical trials in Europe?
Seeking scientific advice in Europe
  • What are the processes?
  • Structure and content of a CTD
The European Medicines Agency
  • Impact of Brexit

Programme - Day two

Applying for a marketing authorisation in the EU with discussion on the impact of Brexit
  • The EU centralised procedure
  • Decentralised procedure
  • Mutual recognition procedure
  • National procedures


Generic applications
  • Requirements
Parallel trade
  • How the process works
  • Impact of Brexit
Managing product labelling
  • Company core data sheets
  • Updates to summary of product characteristics
Post-authorisation obligations: pharmacovigilance, variations and renewals including discussion on the impact of Brexit
  • What to expect
Licence variations
  • Type I and Type II variations
  • Procedures and timelines



Managing and supporting a regulatory affairs department
  • Things to consider
  • Maintaining oversight


Norah Lightowler

Norah Lightowler is a partner in Lightowler Associates, an independent consultancy offering regulatory advice and support to pharmaceutical companies in or proposing to enter the European market for human pharmaceuticals. They are in their twenty fourth year of successful business. She has wide experience in the pharmaceutical and related nutraceutical, herbal and devices industries as a pharmaceutical assessor with the UK regulatory authority and as associate director of European regulatory affairs with an international pharmaceutical company. She is experienced in organising and presenting courses on European regulatory control systems, including requirements, procedures and strategy.

Book now

19-20 Mar 2020
19-20 Mar 2020 Holiday Inn London - Kensington Forum, London GBP 1,299.00
EUR 1,819.00
USD 2,026.00
+ VAT @ 20.00%
Enrol now
29-30 Sep 2020
29-30 Sep 2020 Rembrandt Hotel, London GBP 1,299.00
EUR 1,819.00
USD 2,026.00
+ VAT @ 20.00%
Enrol now

You may also be interested in

Previous customers include...

  • Abbvie Srl
  • Actelion Pharmaceuticals Ltd.
  • Almirall Ltd
  • AZAD Pharmaceutical Ingrediant AG
  • BioMarin Europe Ltd
  • Bray Group Ltd
  • Dafra Pharma International
  • Emas Pharma Ltd
  • Galderma SA
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals Europe Limited
  • Hoffmann-La Roche
  • Johnson & Johnson Ltd
  • Johnson and Johnson
  • Kyowa Kirin Limited
  • Medtronic BioPharma Sàrl
  • NDA Regulatory Science Ltd
  • Orphan Europe
  • Pfizer
  • Shire Pharmaceutical Ltd
  • Shire Pharmaceuticals
  • Takeda GmbH
  • Targovax ASA
  • Teva UK Limited
  • TMC Pharma Services Ltd
  • United Therapeutics Europe Ltd
  • Weifa AS
  • Xellia Pharmaceuticals ApS

Highly recommended course for anyone wishing to learn more about their involvement within the regulatory affairs team at your particular company. The speaker, Norah, was very effective in her presentations and included each delegate and was able to highlight how certain areas were specific to them.

James Smith, Regulatory Affairs Officer, Kyowa Kirin International

I spent a nice moment, and I come back with a lot of information, which is very motivating for my job.

Audrey Chopard-Lallier, Administrative Assistant, Debiopharm International SA

Norah [the speaker] is a very nice and professional person

Sarah Bourgin, Associate Regulatory Affairs Specialist, Medtronic BioPharma Sàrl

Madam Norah Lightowler is an excellent speaker... Presentation was great, everything was clear. The speaker was really nice and she gave a great input about this whole industry and RA.

Valentina Cabula, eCTD Specialist, Xellia Pharmaceuticals ApS

[The speakers were] very knowledgable.

Therese Metzsch, Senior Assistant, Ferring Pharmaceuticals A/S

Very interesting content and well explained by speaker

Charlotte Sellwood, Regulatory Information Executive, Bayer PLC

Useful course to get a broader knowledge and insight about the position of the RA associate.

Dusan Ilic, RA Associate, Mallinckrodt Medical BV

Interesting and informative. Good speaker, very knowledgable.

Marissa Ashfield, Pharmacovigilance - AO, Veterinary Medicines Directorate

The course, presentation and speaker were all brilliant

Jamie Jardine, Administrative Officer, Veterinary Medicines Directorate

Very thorough run-through of all RA procedures and on-going maintenance

Elliot Statham, Business Development Specialist, Creo Pharma Ltd.

All very good

Karen Scott, Regulatory Affairs Team Administrator, Mundipharma Research Limited

The facilities and the event organisers were very good, really welcoming and polite. The venue was a great choice and the refreshments offering was great! Thank you!

Daniel Akhtar, RA Business Support Specialist, Abbvie Ltd.

The course was detailed and interesting. I found the speaker to be engaging and friendly.

Bethan Farley, Regulatory Conformance Manager, Norgine Ltd

Interesting and very enjoyable

Rupinder (Ruby) Bhelay, PA/Team Administrative Assistant - Regulatory Affairs & Quality, Baxalta UK Ltd – now part of Shire Pharmaceuticals (4th Floor)

As someone who has no experience of what the course included, I was able to make some sense in relation to documents that my colleagues write

Joanne Zaninovic, Client Account Assistant, Trilogy Writing & Consulting GmbH

It was a good material, well present and I enjoy the discussions about the context

Barbara Costa, Regulatory Affairs Assistant, Glenmark Pharmaceuticals Europe Limited

Very informative

Roshini Nellailingam, Regulatory Affairs Manager, Emas Pharma Ltd

Good introductory course. Good presentation by a knowledgeable speaker. Interactive case study sessions. Pleasant environment.

Edouard Guillabert, Director & Consultant, GalenAuxi Ltd

The content was packed with relevant information leaving me confident in my role

Christina Obafemi, Regulatory Affairs Specialist II, Teva UK Limited

I would definitely recommend the course for people with very basic knowledge on Regulatory Affairs in Europe. All expected topics were covered sufficiently (even some global regulatory topics). Norah was very clear and happy to answer questions.

Beata Posa, Access to Documents Coordinator, EMEA

I like the content and also the presentation of the slides. Norah was a very pleasure person to explain and clear in everything she was saying.

Barbara Costa, Regulatory Affairs Assistant, Glenmark Pharmaceuticals Europe Limited

Very useful and enjoyable

Hannah Lee, Regulatory Affairs Student Placement, Mundipharma Research Limited